Key Takeaways
- Revenue fell 13.8% YoY, but margins held: Q4 revenue dropped sharply on a tough comp and geopolitical disruption, yet EBITDA margin hit a quarterly high of 11.7%, and the full year delivered the first-ever 10%+ margin.
- The order book is at a 2.5-year high: A record ₹2,416.6 crore backlog, built on a 1.5x full-year book-to-bill, provides strong visibility into FY27.
- The revenue miss was a timing shift, not a loss: Management stated that Q4 revenue delayed by the West Asia crisis and customer approval lags has already moved into Q1 FY27.
- A sales-force rebuild is the growth bet: After a weak FY25 for order intake, new sales leaders are on the ground, and management expects their impact to show in order intake from Q3/Q4 FY27 onward.
- What to watch next quarter: Whether the shifted Q4 revenue actually lands in Q1, the pace of order book conversion into reported growth, and any clarity on U.S. tariffs that could unlock cross-border synergies.
The Quarter in Detail: Revenue Miss and Margin Resilience
- The headline decline: Q4 revenue fell 13.8% YoY, and full-year revenue was down 17%, driven overwhelmingly by the completion of one large A&D order in FY25 and moderated customer offtake.
- Three specific Q4 headwinds: The West Asia war caused material delays on routes through the region, Israeli defense program approvals were held up by the same conflict, and certain NPA approvals from customers did not arrive in time. Management declined to quantify the exact revenue impact of each.
- The miss was a shift, not a loss: Revenue that slipped out of Q4 has moved into Q1 of FY27, per management, making the Q1 print a key early test of the recovery narrative.
- Margin resilience despite the top-line drop: EBITDA margin reached 11.7% in Q4, the highest of any quarter in FY26, and the full year sustained double-digit margins for the first time ever across both India and U.S. operations. This was driven by an improved business mix and tight operating-expense control.
- Gross margin contracted sequentially: The decline reflects product mix shifts quarter-on-quarter, combined with near-term supply chain disruption factors.
- Other expenses rose on a fixed-cost base: The increase from ₹29 cr to ₹44 cr is a mix of India and U.S. operations, broadly fixed in nature, and is expected to benefit from operating leverage when volumes pick up.
- Component availability remains a stress point: Cyclical tightness in electronic components, particularly in the memory sector, is impacting operations given the complexity of boards that use memory.
Krishna Bodanapu: "FY '26 was a 4 year on a growth perspective, and I think that is a reality that stares us."
Order Book: The Foundation for the FY27 Rebound
- Record backlog: The order book stood at ₹2,416.6 crore at year-end, the highest in 2.5 years, providing what management called strong revenue visibility into FY27.
- Book-to-bill above 1x throughout: The full-year ratio was 1.5x, and management stated every quarter of FY26 was above 1x.
- Order intake recovery from a weak FY25: Management acknowledged that FY25 had a challenge in order intake, which led to organizational changes. FY26 order intake growth was at or above the competition's 35-40% level, which management argues will translate into a very strong FY27.
- All orders are external customer POs: Management clarified that the order book contains no intercompany or associate-entity orders.
- Critical materials already ordered for FY27: The company has placed orders for all critical long-lead items for the entire fiscal year to ensure commitments are met.
- Conversion guidance withheld: When asked how much of the order book would convert to revenue in FY27, management declined to provide a number.
Krishna Bodanapu: "If you look at our order intake increase, I mean, you mentioned competition at 35%, 40%. We are also at that percentage between FY '25 and '26. So yes, I mean, extrapolating that, yes, we did have a problem in '25 in order intake, which translated to obviously the revenue that you're seeing in '26. But the fact that we are at competition or even I would argue higher than competition in '26 should translate or will translate, sorry, into a very strong FY '27."
Strategic Pivot: Build-to-Spec and the Move Up the Value Chain
- Build-to-spec is gaining traction: Customers are increasingly seeking partners who engage earlier in the value chain, contributing to specifications, manufacturing decisions, supplier and part selection, and lifecycle management.
- B2S is already profitable: In its first year, the build-to-spec division performed better than expectations and is a profitable division. Fructification into series orders and volume production is expected a couple of years down the line.
- The "Strengthen, Expand, Transform" framework: Strengthen involves deepening presence in key markets and pursuing large deals. Expand targets selective growth in automotive, Indian defense, and AI infrastructure manufacturing, plus vertical integration into cable, sheet metal, and machining. Transform aims to move beyond conventional EMS by developing products and platforms.
- New production wins signal capability upgrades: The company commenced series supply for a new automotive product line and initiated full-scale, repeatable production for a semiconductor mission supply partner. These are not preliminary trials.
- Sales organization rebuilt for strategic selling: Good sales leaders have been hired across geographies and industry verticals over the past year, with more being added in the current quarter, to help progress from a manufacturing partner to a value-adding strategic partner.
Rajendra Velagapudi: "These are not preliminary trials but full scale, repeatable production endeavors signaling our growing capabilities and reinforcing our entry into more rigorous customer environments."
Segment and Geographic Mix: Where the Business Sits
- Aerospace, industrial, and medical remain the largest contributors: Defense share was low, with a 68% YoY decline due to the large order completion in FY25. The "other" segment showed stronger growth, aided by the B2S business.
- Product mix shifting toward Box Build: PCBA remains the largest category at roughly 48% of revenue, but Box Build revenue share is increasing. The "others" category saw strong growth supported by B2S and value-added offerings.
- Geography is overwhelmingly export-driven: Rest of world accounts for more than 90% of revenues, and that proportion is expected to remain the same in the near term.
- Altek margins are structurally lower: U.S. manufacturing inherently carries lower EBITDA margins than India. Altek's growth also carries a tariff overhang, and cross-sell synergies have only just started on a trial basis.
- Cross-pollination upside is contingent on tariffs: When Indian customers go through Altek and U.S. customers move to India, a margin uptick is expected, but this is not factored into current plans and depends on the tariff overhang clearing.
Working Capital and Balance Sheet
- Inventory days elevated on purpose: Advanced stocking for long-lead components and program ramp-ups drove the elevation, but a reduction was seen in Q4 reflecting tighter material planning.
- DSO improved steadily: Receivables days moved from the low 90s to the mid-70s, driven by stronger collection and billing discipline.
- DPO remained higher on average in FY26 compared to FY25.
- Working capital showed signs of normalization in Q4: After being elevated during the revenue-moderation phase, sharper control on inventory and stable receivables produced a healthier cash conversion cycle.
- The long-term target is 100-120 days of net working capital, but management cautioned it will take a couple of years to reach that level.
- IPO proceeds are fully utilized: As of March 2025, all IPO proceeds were deployed in compliance with the stated objectives, and the account stands closed.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Year-over-year growth in all four quarters, "very strong" growth based on order backlog and pipeline | FY27 |
| EBITDA margin sustainability | Confident of sustaining 10-11% margins; operating leverage to add further improvement if top-line growth materializes | Ongoing |
| Order intake | Positive order intake every quarter with book-to-bill ratio above 1x | FY27 |
| Revenue shifted from Q4 | Revenue missed in Q4 has moved into Q1 FY27 | Q1 FY27 |
| New sales team impact | More order intake expected from new sales hires | Q3/Q4 FY27 and beyond |
| Mass manufacturing from anchor clients | Scaling still on track, with uptick expected | Q3/Q4 FY27, scaling in FY28 |
| U.S. tariff clarity | Expects clarity within the next quarter or so | Q1/Q2 FY27 |
| Working capital target | Reach 100-120 days net working capital | A couple of years |
| B2S series production | Fructification to series orders and volume production | A couple of years down the line |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Revenue | ₹369.1 cr, down 13.8% YoY |
| Full-year FY26 revenue | ₹1,261.5 cr, down 17% YoY |
| EBITDA | ₹43.1 cr, down 24.9% YoY |
| EBITDA margin | 11.7%, down 174 bps YoY; highest among all quarters of FY26 |
| PAT | ₹22.4 cr, down 27.6% YoY |
| PAT margin | 6.1%, highest among all quarters of FY26 |
| Full-year FY26 reported EBITDA margin | 10.1%, up 103 bps YoY |
| Full-year FY26 reported PAT | ₹73.3 cr, up 7.7% YoY; margin 5.8%, up 133 bps YoY |
| Full-year FY26 normalized EBITDA | ₹130.2 cr, down 10.2% YoY; margin 10.3%, up 77 bps YoY |
| Full-year FY26 normalized PAT | ₹56.3 cr, down 24% YoY |
| Order book | ₹2,416.6 cr, highest in last 10 quarters; ₹510.5 cr higher than last year |
| Order book net addition in Q4 | ₹67.2 cr |
| Full-year FY26 order intake | Over $208 million |
| Full-year book-to-bill ratio | 1.5x |
| Defense revenue share YoY change | Down 68% due to large order completion in FY25 |
| PCBA revenue share | ~48% of revenues |
| Export revenue share | Over 90% of revenues |
| DSO | Improved from low 90s to mid-70s |
| Sales pipeline | Closer to $0.5 billion |
| M&A evaluation expenses (one-off) | ₹1.78 cr |
| Wage code impact (one-off) | ₹1.64 cr |